drugset / Trial / NCT01624779

Intrathecal Transplantation Of Autologous Adipose Tissue Derived MSC in the Patients With Spinal Cord Injury

NCT01624779 ↗

Phase 1 Completed 15 enrolled Bukwang Pharmaceutical
FactorialOpen-labelTreatment

Summary

The effect of intrathecal transplantation of autologous adipose tissue derived mesenchymal stem cells in the patients with spinal cord injury, Phase I Clinical study.

Timeline

Start
2012-04
Primary completion
2014-05
Completion
2014-05

Drugs

EvaluationDrugModalityDoseRoute
Subject autologous adipose tissue derived mesenchymal stem cells Cell therapy 3 ml Intrathecal
Subject autologous adipose tissue derived mesenchymal stem cells Cell therapy 9e+07 cells Intrathecal

Indications